Seres Therapeutics (MCRB) Reaches $11.99 After 4.00% Up Move; Blackrock Advisors Has Lifted By $2.73 Million Its Piper Jaffray Cos (PJC) Position

July 18, 2017 - By Hazel Jackson

Blackrock Advisors Llc increased Piper Jaffray Cos (PJC) stake by 48.65% reported in 2016Q4 SEC filing. Blackrock Advisors Llc acquired 37,971 shares as Piper Jaffray Cos (PJC)’s stock declined 24.06%. The Blackrock Advisors Llc holds 116,023 shares with $8.41M value, up from 78,052 last quarter. Piper Jaffray Cos now has $967.06M valuation. The stock declined 1.32% or $0.85 reaching $63.7 on the news. About 11,071 shares traded. Piper Jaffray Companies (NYSE:PJC) has risen 43.41% since July 18, 2016 and is uptrending. It has outperformed by 26.71% the S&P500.

The stock of Seres Therapeutics Inc (NASDAQ:MCRB) is a huge mover today! About 65,343 shares traded. Seres Therapeutics Inc (NASDAQ:MCRB) has declined 64.58% since July 18, 2016 and is downtrending. It has underperformed by 81.28% the S&P500.The move comes after 9 months positive chart setup for the $492.89M company. It was reported on Jul, 18 by Barchart.com. We have $12.47 PT which if reached, will make NASDAQ:MCRB worth $19.72M more.

Blackrock Advisors Llc decreased Reliance Steel & Aluminum Co (NYSE:RS) stake by 14,114 shares to 434,966 valued at $34.60M in 2016Q4. It also reduced Agilent Technologies Inc (NYSE:A) stake by 101,059 shares and now owns 1.03M shares. Ptc Inc (NASDAQ:PTC) was reduced too.

Investors sentiment increased to 1.26 in 2016 Q4. Its up 0.06, from 1.2 in 2016Q3. It increased, as 13 investors sold PJC shares while 55 reduced holdings. 40 funds opened positions while 46 raised stakes. 10.34 million shares or 2.28% more from 10.11 million shares in 2016Q3 were reported. Deutsche Comml Bank Ag holds 0% or 31,955 shares. Renaissance Techs Lc invested in 29,300 shares. Blackrock Advsr Limited Liability Company invested 0.01% in Piper Jaffray Companies (NYSE:PJC). Comerica National Bank & Trust holds 0.01% or 15,174 shares. Manufacturers Life Insurance Co The has 0% invested in Piper Jaffray Companies (NYSE:PJC). Sector Pension Inv Board stated it has 0.01% of its portfolio in Piper Jaffray Companies (NYSE:PJC). Driehaus Capital Mngmt Lc invested in 56,572 shares or 0.15% of the stock. Finemark Bancshares Trust reported 0% of its portfolio in Piper Jaffray Companies (NYSE:PJC). Comml Bank Of Montreal Can invested in 5,950 shares. California State Teachers Retirement has 0% invested in Piper Jaffray Companies (NYSE:PJC). Principal Finance Group Inc Inc accumulated 213,696 shares. Hillsdale Investment Mgmt stated it has 13,300 shares or 0.2% of all its holdings. Benjamin F Edwards & Inc holds 43 shares. Ameriprise Fincl accumulated 181,884 shares. Nationwide Fund Advsrs invested in 34,664 shares.

Among 7 analysts covering Piper Jaffray (NYSE:PJC), 1 have Buy rating, 2 Sell and 4 Hold. Therefore 14% are positive. Piper Jaffray had 14 analyst reports since August 11, 2015 according to SRatingsIntel. As per Friday, April 28, the company rating was maintained by TD Securities. The firm earned “Buy” rating on Tuesday, September 22 by Sandler O’Neill. BMO Capital Markets maintained Piper Jaffray Companies (NYSE:PJC) on Friday, April 28 with “Market Perform” rating. Keefe Bruyette & Woods upgraded the shares of PJC in report on Friday, October 30 to “Outperform” rating. The stock has “Mkt Perform” rating by Keefe Bruyette & Woods on Friday, December 11. The firm has “Sell” rating by Desjardins Securities given on Friday, April 28. Zacks upgraded it to “Hold” rating and $52 target in Tuesday, August 11 report.

Since February 3, 2017, it had 0 insider purchases, and 13 insider sales for $8.14 million activity. $436,879 worth of Piper Jaffray Companies (NYSE:PJC) was sold by Winges Martin Bradley. Crawshaw Christopher D sold $797,590 worth of stock. Klinefelter Jeffrey P had sold 4,650 shares worth $358,659 on Friday, February 10. Shares for $407,530 were sold by LaRue R Scott on Wednesday, February 15. Abraham Chad R had sold 13,215 shares worth $995,305. 7,000 shares valued at $532,621 were sold by Schoneman Debbra L. on Tuesday, February 7. $726,475 worth of Piper Jaffray Companies (NYSE:PJC) was sold by DUFF ANDREW S on Friday, February 3.

Analysts await Seres Therapeutics Inc (NASDAQ:MCRB) to report earnings on August, 10. They expect $-0.59 earnings per share, up 15.71% or $0.11 from last year’s $-0.7 per share. After $-0.63 actual earnings per share reported by Seres Therapeutics Inc for the previous quarter, Wall Street now forecasts -6.35% EPS growth.